Back

ESMO Plenary Dec 2022 - ESMO Virtual Plenaries: Dec 2022

Dec 15 - Dec 16, 2022 | LuganoSwitzerland

LARVOL is not affiliated with ESMO Virtual Plenaries: Dec 2022 and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 1 titles linked to Trials

An ad hoc interim overall survival results of niraparib with individualized starting dose as maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer (NORA): A double-blind, randomized, placebo-controlled, phase III trial

1 Twitter Reactions